Ketamine therapy myths are everywhere, and they can keep people from exploring a treatment option that might actually help. Ketamine therapy has grown a lot in recent years, and with that growth has come a lot of misinformation. Some of it comes from outdated ideas about ketamine as a party drug. Some comes from confusion with newer treatments like Spravato®. Here’s a clear look at five of the most common ketamine therapy myths, and what’s actually true.
Myth 1: “Ketamine Therapy Is Just Recreational Drug Use in a Clinical Setting”
The reality: The dose, delivery method, and monitoring involved in clinical ketamine therapy are entirely different from recreational use. In a clinical setting, ketamine is administered intravenously in carefully calculated, individualized doses, well below levels associated with recreational use, by trained clinical staff who monitor vital signs throughout the session. The goal isn’t a “high.” It’s a controlled, brief window during which the brain may become more receptive to positive change.
Myth 2: “Ketamine Just Masks Symptoms Like a Typical Medication”
The reality: Traditional antidepressants generally work by adjusting neurotransmitter levels day to day, which is why they often need to be taken continuously to maintain effect. Ketamine’s research is focused on something different: its potential role in supporting neuroplasticity, the brain’s ability to form new neural connections. That’s part of why clinics like ours describe this as brain health care, not just symptom management. It’s about exploring change at a deeper level, not covering up how you feel in the moment.
Myth 3: “Ketamine Therapy Is Unsafe or Unregulated”
The reality: Ketamine has been used safely in medical settings, including surgical anesthesia, for decades. In a reputable clinic, treatment is administered by qualified clinical staff. At Scenic City Neurotherapy, that means Certified Registered Nurse Anesthesiologists (CRNAs) with extensive anesthesia experience, in a monitored environment with safety protocols in place before, during, and after each session. That’s a very different picture from unsupervised or at-home use, which carries real risks and isn’t something we recommend or support.
Myth 4: “If Antidepressants Didn’t Work for Me, Nothing Will”
The reality: This is one of the most common, and most discouraging, myths we hear. Traditional antidepressants don’t work the same way for everyone, and a lack of response to one type of treatment doesn’t mean every option has been exhausted. Ketamine therapy is often explored specifically by people who feel like they’ve tried everything else, because its mechanism works differently than standard antidepressants. Exploring another option isn’t giving up. It’s often the next reasonable step.
Myth 5: “Ketamine Therapy Is a Last Resort With No Real Science Behind It”
The reality: Ketamine’s use for treatment-resistant depression and related conditions has been the subject of a growing body of clinical research over the past two decades, including peer-reviewed research published by the National Institutes of Health examining its use in treatment-resistant patients. Scenic City Neurotherapy is also an active research site, contributing data on patient response as part of the broader effort to better understand how individualized ketamine protocols like MSKIT® may support brain health. This is an evolving, evidence-informed field, not a fringe treatment.
Note: Any specific data points about research outcomes or treatment volumes should be confirmed with the clinical team before publishing, since these figures are updated periodically as the research program continues.
More Ketamine Therapy Myths, Answered (FAQ)
The questions below cover a few more common ketamine therapy myths and misunderstandings.
Is ketamine therapy safe? When administered in a clinical setting by trained providers with proper monitoring, ketamine therapy has an established safety profile. Every patient’s history is reviewed individually before treatment begins.
Does ketamine therapy work like a typical antidepressant? No. Traditional antidepressants and ketamine are believed to work through different mechanisms. Ketamine’s research is centered on neuroplasticity, while most antidepressants focus on adjusting neurotransmitter levels over time.
Is ketamine therapy only for people who’ve tried everything else? Many people explore ketamine therapy after other approaches haven’t provided the results they hoped for, but it’s worth discussing during a consultation regardless of where you are in your treatment history.
What makes MSKIT® different from standard ketamine infusion therapy? MSKIT® (Minimally Stimulated Ketamine Infusion Therapy) is Scenic City Neurotherapy’s proprietary, individualized protocol, developed with a focus on personalized dosing and a research-driven approach to brain health rather than a one-size-fits-all infusion.
Have more questions about how ketamine therapy works? Schedule a consultation with our team. We’re happy to walk through what the research says and answer your specific questions.
Follow us! @sceniccityneuro